Gynecologic Oncology

Novel engineered cytokine plus pembrolizumab to treat ovarian cancer

November 24, 2020

Heavily pretreated ovarian cancer patients who received a combination therapy of a novel engineered interleukin-2 (IL-2) cytokine plus pembrolizumab achieved an acceptable safety profile, according to a small cohort of an ongoing phase 1/2 trial.

Recurrence of high-grade cervical dysplasia

September 18, 2020

Women with high-grade cervical dysplasia are much less likely to have recurrence after primary conization if they undergo laser conization than a loop electrosurgical excision procedure (LEEP), according to a 5-year follow-up study.